Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm ...

Shoko Kawata is the first mayor to take maternity leave in Japan’s history. Her decision has prompted debate about gender discrimination in the work force. By Javier C. Hernández and Kiuko Notoya The ...

The lawsuit aims to hold fossil fuel companies responsible for a heat wave in Portland five years ago. The industry says the case should be thrown out. By Karen Zraick Gregg Phillips was in charge of ...

Health news moves fast, with new studies, findings, and regulatory updates changing the landscape daily. Insights from advocates and celebrities can also impact the public awareness of certain health ...

June 26, 2026 • To mark the occasion of Miles Davis' centennial, trumpeter Keyon Harrold put on a concert at Carnegie Hall and shared a candid conversation about the legend with Christian McBride.

Neuroscience is a multidisciplinary science that is concerned with the study of the structure and function of the nervous system. It encompasses the evolution, development, cellular and molecular ...

New! Sign up for our free email newsletter.

US Food and Drug Administration Approval Summary: Talazoparib in Combination With Enzalutamide for Treatment of Patients With Homologous Recombination Repair Gene-Mutated Metastatic ...

Healthline News reports on emerging research, new treatments, diet, exercise, and trending topics in health and wellness. All articles are written by our network of editors and contributors.

The Medical News Today news team reports on emerging science, cutting-edge research, new treatments, and trending topics in health and medicine. All articles are written by our network of editors and ...

Microbiology is the study of microscopic organisms, such as bacteria, viruses, archaea, fungi and protozoa. This discipline includes fundamental research on the biochemistry, physiology, cell biology, ...

Prior authorization remains a major barrier to biologic access in AD. Dr Chuck Vega covers denial rates, appeal outcomes, and the clinical data that make the fight worthwhile.